Skip to main content
Erschienen in: World Journal of Surgery 8/2008

01.08.2008

Edmondson-Steiner Grading Increases the Predictive Efficiency of TNM Staging for Long-term Survival of Patients with Hepatocellular Carcinoma After Curative Resection

verfasst von: Li Zhou, Jing-An Rui, Da-Xiong Ye, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu

Erschienen in: World Journal of Surgery | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The 6th edition TNM staging (TNM-6) for hepatocellular carcinoma (HCC) has been recommended. However, its superiority, in contrast to the previous 5th edition (TNM-5), has not been fully recognized. Besides, tumor differentiation was not included. The current study was designed to compare the value of these two staging systems and, more importantly, to elucidate whether Edmondson-Steiner grading, a well-acknowledged histological classification, is helpful in further discriminating different prognosis of HCC.

Methods

Prospectively collected clinicopathological and follow-up data of consecutive 171 patients with HCC undergoing curative hepatic resection (CHR) were reviewed retrospectively. The impacts of variables on survival were determined by univariate and multivariate statistical analyses.

Results

The differences of survival between stages of the TNM-6 and TNM-5 were almost significant, except for disease-free survival for TNM-5. Moreover, TNM-6 might be a more powerful prognostic predictor compared with TNM-5, although their impacts on survival were all not independent, unlike Edmondson-Steiner grading. For patients with each stage of TNM-6, Edmondson-Steiner grade was the sole significant variable in both univariate and multivariate analyses. Finally, a novel scoring criteria (prognostic scoring for CHR, PSCHR) integrating Edmondson-Steiner grading and TNM-6 was attempted and statistically shown to be of independent significance and stronger predicting value for prognosis of curatively resected HCC.

Conclusion

TNM-6 revealed to be more significantly prognostic than TNM-5 in patients with HCC after curative hepatic resection. Edmondson-Steiner grading could raise the predictive efficiency of TNM-6 for postresectional survival of patients with HCC. Therefore, PSCHR containing Edmondson-Steiner grading was preliminarily proposed.
Literatur
1.
Zurück zum Zitat Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606PubMedCrossRef Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606PubMedCrossRef
2.
Zurück zum Zitat Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29PubMedCrossRef Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29PubMedCrossRef
3.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMed
4.
Zurück zum Zitat Primack A, Vogel CL, Kyalwazi SK, Ziegler JL, Simon R, Anthony PP (1975) A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer 35:1357–1364PubMedCrossRef Primack A, Vogel CL, Kyalwazi SK, Ziegler JL, Simon R, Anthony PP (1975) A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer 35:1357–1364PubMedCrossRef
5.
Zurück zum Zitat Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928PubMedCrossRef Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928PubMedCrossRef
6.
Zurück zum Zitat The Cancer of the Liver Italian Program (CLIP) Investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751–755CrossRef The Cancer of the Liver Italian Program (CLIP) Investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751–755CrossRef
7.
Zurück zum Zitat Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–337PubMedCrossRef Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–337PubMedCrossRef
8.
Zurück zum Zitat Leung TW, Tang AM, Zee B et al (2002) Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 94:1760–1769PubMedCrossRef Leung TW, Tang AM, Zee B et al (2002) Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 94:1760–1769PubMedCrossRef
9.
Zurück zum Zitat Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score). J Gastroenterol 38:207–215PubMedCrossRef Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score). J Gastroenterol 38:207–215PubMedCrossRef
10.
Zurück zum Zitat Fleming I, Cooper J, Hensen D (1997) Liver AJCC cancer staging manual. 5th edn. Lippincott-Raven, Philadelphia Fleming I, Cooper J, Hensen D (1997) Liver AJCC cancer staging manual. 5th edn. Lippincott-Raven, Philadelphia
11.
Zurück zum Zitat Huang YH, Chen CH, Chang TT et al (2005) Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20:765–771PubMedCrossRef Huang YH, Chen CH, Chang TT et al (2005) Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20:765–771PubMedCrossRef
12.
Zurück zum Zitat Farinati F, Rinaldi M, Gianni S, Naccarato R (2000) How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89:2266–2273PubMedCrossRef Farinati F, Rinaldi M, Gianni S, Naccarato R (2000) How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89:2266–2273PubMedCrossRef
13.
Zurück zum Zitat Anonymous (2002) Liver including intrahepatic bile ducts. In: Greene F, Page D, Fleming I (eds) American Joint Committee on cancer staging manual. 6th edn. Springer, New York, pp 131–144 Anonymous (2002) Liver including intrahepatic bile ducts. In: Greene F, Page D, Fleming I (eds) American Joint Committee on cancer staging manual. 6th edn. Springer, New York, pp 131–144
14.
Zurück zum Zitat Vauthey JN, Lauwers GY, Esnaola NF et al (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20:1527–1536PubMedCrossRef Vauthey JN, Lauwers GY, Esnaola NF et al (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20:1527–1536PubMedCrossRef
15.
Zurück zum Zitat Lei HJ, Chau GY, Lui WY et al (2006) Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 203:426–435PubMedCrossRef Lei HJ, Chau GY, Lui WY et al (2006) Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 203:426–435PubMedCrossRef
16.
Zurück zum Zitat Ramacciato G, Mercantini P, Cautero N et al (2005) Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12:289–297PubMedCrossRef Ramacciato G, Mercantini P, Cautero N et al (2005) Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12:289–297PubMedCrossRef
17.
Zurück zum Zitat Varotti G, Ramacciato G, Ercolani G et al (2005) Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 31:760–767PubMedCrossRef Varotti G, Ramacciato G, Ercolani G et al (2005) Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 31:760–767PubMedCrossRef
18.
Zurück zum Zitat Kee KM, Wang JH, Lee CM et al (2007) Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 120:2650–2655PubMedCrossRef Kee KM, Wang JH, Lee CM et al (2007) Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 120:2650–2655PubMedCrossRef
19.
Zurück zum Zitat Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922PubMedCrossRef Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922PubMedCrossRef
20.
Zurück zum Zitat Qiang L, Huikai L, Butt K, Wang PP, Hao X (2006) Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg 30:439–445PubMedCrossRef Qiang L, Huikai L, Butt K, Wang PP, Hao X (2006) Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg 30:439–445PubMedCrossRef
21.
Zurück zum Zitat Shah SA, Greig PD, Gallinger S et al (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202:275–283PubMedCrossRef Shah SA, Greig PD, Gallinger S et al (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202:275–283PubMedCrossRef
22.
Zurück zum Zitat Martins A, Cortez-Pinto H, Marques-Vidal P et al (2006) Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int 26:680–687PubMedCrossRef Martins A, Cortez-Pinto H, Marques-Vidal P et al (2006) Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int 26:680–687PubMedCrossRef
23.
Zurück zum Zitat Tanigawa N, Lu C, Mitsui T, Miura S (1997) Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 26:1216–1223PubMed Tanigawa N, Lu C, Mitsui T, Miura S (1997) Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 26:1216–1223PubMed
24.
Zurück zum Zitat Horigome H, Nomura T, Saso K, Itoh M (1999) Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 94:1914–1917PubMedCrossRef Horigome H, Nomura T, Saso K, Itoh M (1999) Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 94:1914–1917PubMedCrossRef
25.
Zurück zum Zitat Tamura S, Kato T, Berho M et al (2001) Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 136:25–30PubMedCrossRef Tamura S, Kato T, Berho M et al (2001) Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 136:25–30PubMedCrossRef
26.
Zurück zum Zitat Si MS, Amersi F, Golish SR et al (2003) Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg 69:879–885PubMed Si MS, Amersi F, Golish SR et al (2003) Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg 69:879–885PubMed
27.
Zurück zum Zitat Roayaie S, Schwartz JD, Sung MW et al (2004) Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 10:534–540PubMedCrossRef Roayaie S, Schwartz JD, Sung MW et al (2004) Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 10:534–540PubMedCrossRef
28.
Zurück zum Zitat Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 127:1714–1723PubMedCrossRef Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 127:1714–1723PubMedCrossRef
29.
Zurück zum Zitat Kubo S, Tanaka H, Shuto T et al (2005) Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 35:216–222PubMedCrossRef Kubo S, Tanaka H, Shuto T et al (2005) Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 35:216–222PubMedCrossRef
30.
Zurück zum Zitat Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156PubMedCrossRef Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156PubMedCrossRef
31.
Zurück zum Zitat Qian YB, Zhang JB, Wu WZ et al (2006) P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer 107:1562–1569PubMedCrossRef Qian YB, Zhang JB, Wu WZ et al (2006) P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer 107:1562–1569PubMedCrossRef
32.
Zurück zum Zitat Zhou L, Rui JA, Wang SB et al (2003) Multi-modal serial therapy for primary liver cancer in senile patients: a report of 153 cases. Zhonghua Zhong Liu Za Zhi 25:404–406PubMed Zhou L, Rui JA, Wang SB et al (2003) Multi-modal serial therapy for primary liver cancer in senile patients: a report of 153 cases. Zhonghua Zhong Liu Za Zhi 25:404–406PubMed
33.
Zurück zum Zitat Qu Q, Rui JA, Wang SB et al (2006) Comparison of different clinical staging systems for hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 28:155–158PubMed Qu Q, Rui JA, Wang SB et al (2006) Comparison of different clinical staging systems for hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 28:155–158PubMed
34.
Zurück zum Zitat Zhou L, Rui JA, Wang SB et al (2006) Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 32:767–772PubMedCrossRef Zhou L, Rui JA, Wang SB et al (2006) Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 32:767–772PubMedCrossRef
35.
Zurück zum Zitat Zhou L, Rui JA, Wang SB et al (2007) Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection. J Surg Oncol 95:298–303PubMedCrossRef Zhou L, Rui JA, Wang SB et al (2007) Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection. J Surg Oncol 95:298–303PubMedCrossRef
36.
Zurück zum Zitat Zhou L, Rui JA, Wang SB et al (2007) Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 31:1782–1787PubMedCrossRef Zhou L, Rui JA, Wang SB et al (2007) Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 31:1782–1787PubMedCrossRef
37.
Zurück zum Zitat Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503PubMedCrossRef Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503PubMedCrossRef
38.
Zurück zum Zitat Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K (1995) Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 76:399–405PubMedCrossRef Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K (1995) Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 76:399–405PubMedCrossRef
39.
Zurück zum Zitat Chen TW, Chu CM, Yu JC et al (2007) Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy. Eur J Surg Oncol 33:480–487PubMedCrossRef Chen TW, Chu CM, Yu JC et al (2007) Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy. Eur J Surg Oncol 33:480–487PubMedCrossRef
40.
Zurück zum Zitat Zavaglia C, De Carlis L, Alberti AB et al (2005) Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100:2708–2716PubMedCrossRef Zavaglia C, De Carlis L, Alberti AB et al (2005) Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100:2708–2716PubMedCrossRef
41.
Zurück zum Zitat Wada H, Nagano H, Yamamoto H et al (2006) Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. Liver Int 26:414–423PubMedCrossRef Wada H, Nagano H, Yamamoto H et al (2006) Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. Liver Int 26:414–423PubMedCrossRef
42.
Zurück zum Zitat Oishi K, Itamoto T, Amano H et al (2007) Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol 95:311–316PubMedCrossRef Oishi K, Itamoto T, Amano H et al (2007) Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol 95:311–316PubMedCrossRef
43.
Zurück zum Zitat Le Treut YP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10:855–862PubMedCrossRef Le Treut YP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10:855–862PubMedCrossRef
Metadaten
Titel
Edmondson-Steiner Grading Increases the Predictive Efficiency of TNM Staging for Long-term Survival of Patients with Hepatocellular Carcinoma After Curative Resection
verfasst von
Li Zhou
Jing-An Rui
Da-Xiong Ye
Shao-Bin Wang
Shu-Guang Chen
Qiang Qu
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 8/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9615-8

Weitere Artikel der Ausgabe 8/2008

World Journal of Surgery 8/2008 Zur Ausgabe

Letter

Reply

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.